Genetic variability in the human immune system may affect susceptibility to and severity of infection by SARS-CoV-2, a novel coronavirus which causes the...
A little known yet powerful function of overactive white blood cells known as neutrophils — the ability to form neutrophil extracellular traps (NETs)...
A team of researchers from the Royal Women’s Hospital, Monash University and the Alfred Hospital has successfully tested, in a simulated environment,...
According to a new study published in the European Respiratory Journal, smokers and individuals with chronic obstructive pulmonary disease (COPD) have...
In a phylogenetic network analysis of the first 160 complete genomes of SARS-CoV-2 to be sequenced from human patients, an international team of scientists...
An orally bioavailable prodrug called EIDD-2801 (β-D-N4-hydroxycytidine-5’-isopropyl ester) has broad spectrum antiviral activity against SARS-CoV-2,...
Four types of human coronaviruses (OC43, 229E, HKU1 and NL63) are highly seasonal and appear to transmit similarly to influenza A (H3N2) in the same population,...
In new laboratory experiments conducted by researchers from the University of Maryland, the University of Hong Kong and Harvard School of Public Health,...
According to a report by University of Göttingen researchers Christian Bommer and Sebastian Vollmer, the number of confirmed COVID-19 cases officially...
Healthcare professionals on the COVID-19 frontline are spending many hours a day wearing face masks, and many members of the general public are doing the...
An approach called the wastewater-based epidemiology (WBE), which is already recognized as an effective way to trace illicit drugs and obtain information...
A team of scientists from the Biomedicine Discovery Institute at Monash University and the Peter Doherty Institute of Infection and Immunity (Doherty Institute)...
A trial drug called APN01 or human recombinant soluble ACE2 (hrsACE2) can significantly block early stages of SARS-CoV-2 infections, according to a paper...
The Surviving Sepsis Campaign COVID-19 panel, which includes 36 experts from 12 countries, has issued new guidelines for health-care workers treating intensive...
A team of researchers at the University of Pittsburgh and Erasmus Medical Center Rotterdam has developed a potential vaccine against SARS-CoV-2, a novel...
Responding to an outbreak of SARS-CoV-2, a novel coronavirus that causes the COVID-19 disease, in December 2019, China banned travel to and from Wuhan...
Since humans haven’t previously been exposed to the SARS-CoV-2 coronavirus, our bodies aren’t well equipped to deal with being infected by it. A vaccine...
About 1 in 5 patients infected with SARS-CoV-2, a new coronavirus that causes the COVID-19 disease, are also infected with other respiratory viruses, according...
Two new papers published in the journal Antimicrobial Agents and Chemotherapy provide a summary of therapeutic compounds that showed potential in fighting...
Symptoms of COVID-19, the respiratory disease caused by the SARS-CoV-2 coronavirus, typically include a dry cough, fever and shortness of breath. But evidence...
